Skip to main content
. 2022 May 27;12:785350. doi: 10.3389/fonc.2022.785350

Table 5.

Median OS as calculated from the end of radiation treatment based on the type of radiation.

Type of Radiation Immunotherapy Timing Median OS from SBRT (months) p-value
SBRT Before 6.538 0.64
Concurrent/After 12.583
SRS Before* 3.088 0.0098
Concurrent/After* 9.593

*Indicates significance. OS, Overall survival; SBRT, Stereotactic Body Radiotherapy; SRS, Stereotactic Radiosurgery.